Is Clobetasol a High Potency Steroid?
Yes, clobetasol propionate is classified as a super-high potency (Class I) topical corticosteroid, the strongest category in standard potency scales used by dermatologists.[1][2]
How Do Topical Steroid Potency Classes Work?
Steroids are grouped into seven classes (I strongest to VII weakest) based on vasoconstrictor assays, which measure skin-blanching effects. Clobetasol ranks in Class I alongside betamethasone dipropionate, showing the most potent anti-inflammatory action for severe conditions like psoriasis or eczema.[1][3]
What Conditions Is Clobetasol Used For?
Doctors prescribe it short-term for resistant dermatitis, lichen planus, or scalp psoriasis unresponsive to milder steroids. It's available as cream, ointment, foam, or shampoo, typically 0.05% strength.[2][4]
What Are the Risks of Using Such a Potent Steroid?
High potency brings higher risks: skin thinning (atrophy), stretch marks (striae), telangiectasia, and adrenal suppression with prolonged use, especially on large areas or in children. Limit to 2 weeks; avoid face/genitals unless directed.[1][3][5]
How Does Clobetasol Compare to Other Steroids?
| Steroid | Potency Class | Example Use |
|---------|---------------|-------------|
| Clobetasol | I (super-high) | Severe plaques |
| Betamethasone valerate | III (high) | Moderate eczema |
| Triamcinolone | IV (medium) | Mild dermatitis |
| Hydrocortisone | VII (low) | OTC rashes |
Clobetasol is 600 times more potent than hydrocortisone by vasoconstriction metrics.[1][2]
Are There Safer Alternatives for Milder Cases?
For less severe inflammation, start with mid-potency options like mometasone (Class II) or low-potency hydrocortisone. Non-steroid topicals like calcineurin inhibitors (tacrolimus) suit sensitive areas.[3][4]
Who Makes Clobetasol and What's the Generic Status?
Originally from GlaxoSmithKline, generics from multiple makers (e.g., Teva, Perrigo) dominate since patent expiry. No active patents block U.S. generics; check DrugPatentWatch.com for formulations.[6]
Sources
[1] American Academy of Dermatology: Topical Corticosteroids
[2] StatPearls: Clobetasol
[3] UpToDate: Topical Corticosteroids Potency
[4] FDA: Clobetasol Labeling
[5] Mayo Clinic: Clobetasol Side Effects
[6] DrugPatentWatch.com: Clobetasol Patents